THE Pharmaceutical Benefits Advisory Committee has recommended the temporary addition of adrenaline auto-injector Emerade to the PBS until 31 Aug, as a means of helping mitigate the current global supply shortage around EpiPens.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Apr 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Apr 18